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Abstract
Background: ST elevation myocardial infarction (STEMI) is the most common acute coronary 
syndrome in adults, and requiring immediate reperfusion. Primary percutaneous coronary 
intervention (PCI) is the main reperfusion therapy, but because of many limitations, fibrinolytic 
is often chosen. Fibrinolytic have high failure risk, so it is important to be able to predict whether 
this therapy will fail or not. This research aim to create a scoring system to predict failed 
fibrinolytic in STEMI patients.
Methods: This is retrospective cohort study using medical records data from Dr. Sardjito General 
Hospital in Yogyakarta, recorded in June 2014-December 2015. The population was STEMI 
patients that reperfused with streptokinase regiment. Determination of failed fibrinolytic was 
using the difference in the ST segment elevation of the pre and post fibrinolytic electrocardiogram 
(ECG).  The clinical variables of subjects were recorded.  The statistical analysis was done and 
scoring system was constructed. 
Results: A total of 105 patients with mean age of 57.82±9.59 years were included in this study. 
Subjects with failed fibrinolytic was 53 patients (50.5%). Several variables were independently 
associated with failed fibrinolytis, i.e.  the onset of  ≥ 6 hours, hyperglycemia, and the location 
of anterior infarction (OR = 11.3, p = 0.000; OR = 6.11, p = 0.003 and OR = 10.5, p = 0.001, 
respectively). After scoring system was constructed, it was found that score ≥ 2 predict failed 
fibinolytic, with 53% sensitivity and 94% specificity.
Conclusions : Scoring system consisting of onset ≥ 6 hours, hyperglycemia in arrival, and 
anterior infarct location, can be used to predict failed fibrinolytic in STEMI patients using 
streptokinase with 53% sensitivity and 94% specificity.
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Background
ST elevation myocardial infarction (STEMI) 
is the most common acute coronary syndrome 
in adults. This disease is mainly caused by 
intracoronary thrombosis after atherosklerotic 
plaque rupture in coronary artery. Mortality rate 
in 24 hours in STEMI is 30%, whereas 5-10% 
survived patients will die after 1 year. The presence 
of ST segment elevation in electrocardiogram 
(ECG) signals active transmural damage. Without 
immediate reperfusion therapy, the damage will 
develop into irreversible myocardial necrosis, which 
indicated by the presence of Q waves on ECG. This 
necrosis can evolve into heart failure and become 
a substrate for lethal arrhytmia events.1
Thrombus occlusion will persist in most 
of STEMI patients. Timely reperfusion therapy 
is the most effective step in restoring the 
balance between oxygen supply and demand in 
myocardium. There are two ways of reperfusion, ie 
with primary percutaneous coronary intervention 
(PCI), or fibrinolytic therapy. Primary PCI is the 
preferred reperfusion strategy if it can be done 
within 120 minutes of first medical contact in 
PCI uncapable hospitals, or 90 minutes on 
PCI capable hospitals. In Indonesia, only a 
few hospitals have this facility. Therefore there 
are limitations in conducting timely primary 
PCI, fibrinolytic therapy remains an important 
reperfusion strategy in STEMI patients.2 In a 
study by Fibrinolytic Therapy Trialist (FTT) group 
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showed that administration of fibrinolytic therapy 
prevents 20-30 deaths in 1000 patients with 
mortality reduction of 25%.3
One of the shortcoming of fibrinolytic 
therapy is the presence of treatment failure. 
Fibrinolytic therapy have success level that 
depends on the fibrinolytic drug used. Until 
now, one of the most commonly used drug 
is streptokinase, which has a low success 
rate of 60-68%.4 While in failed fibrinolytic 
patients, emergency rescue PCI should be done 
immediately. Therefore, it is important to be able 
to estimate the chance of failed fibrinolytic in 
STEMI patients that was done fibrinolytic using 
streptokinase.
There are various kinds of predictors that 
can predict the failure of fibrinolytic therapy, but 
to determine the prognosis of fibrinolytic therapy 
using the predictors are quite complicated. Scoring 
system is an easy way to facilitate determination of 
the prognosis of a disease or therapy.5 However, 
until now author did not find a scoring system to 
predict the failure of fibrinolytic therapy.
Methods 
This is retrospective cohort study using 
medical records data from Dr. Sardjito General 
Hospital in Yogyakarta, recorded in June 2014-
December 2015. The subjects of thise study 
was STEMI patients that were undergone 
reperfusion strategy with streptokinase regiment. 
Determination of failed fibrinolytic was using 
the difference in the ST segment elevation of 
the pre and post fibrinolytic electrocardiogram 
(ECG) based on ACC/AHA criteria. Several 
demography, clinical and laboratory parameters 
of the subjects were recorded and analyse as 
predictors of failed fibrinolytic. 
Statistical analysis was performed with 
bivariate and multivariate analysis  and scoring 
system with weight value calculation was 
constructed. A p value < 0.05 was considered 
as statistical significance. 
This research is a non-experimental 
research so that there is no specific intervention 
on the subject. This study was using secondary 
data from patients medical records. This study 
did not influence patient’s disease management. 
This study was conducted after approval 
from the ethics committee of the Faculty of 
Medicine Universitas Gadjah Mada, Yogyakarta, 
Indonesia. 
Result
The retrieval of data was based on medical 
records in the period of June 2014 to December 
2015. Total subjects who met the inclusion criteria 
were 120 patients. A total of 15 patients were 
excluded because there is a bundle branch block 
in ECG or premature cessation of fibrinolytic.
An ECG assessment was performed 
by two observers who first tested the Kappa 
Table 1. Characteristics of STEMI patients 
that was done fibrinolytic using streptokinase 
regiment
Variables Value(n=105)
Sex, n(%)
      Male 95 (90.5%)
      Female 10 (9.5%)
Age (years old), mean±SD 57.82 ± 9.59
Elderly ( > 75 years old), n(%) 6 (5.7%)
Clinical
Hypertension,  n (%) 48 (45.7%)
Diabetes, n (%) 17 (16%)
Not smoker,  n (%) 23 (21.9%)
Killip class > 1,  n (%) 20 (19%)
Onset
≥ 6 hours,  n (%) 29 (27.6%)
< 6 hours,  n (%) 76 (72.4%)
Laboratory examination
Leukocytosis/neutrophilia, n (%) 88 (83.8%)
Hyperglycemia, n (%) 26 (24.8%)
Blood glucose, mean±SD 171 ± 75.97
Increased creatinine level : n (%) 42 (40%)
Creatinine level, mean±SD 1.38 ± 0.75
Electrocardiography 
Anterior infarction,  n (%) 60 (57.1%)
Failed fibrinolytic; n (%) 53 (50.5%)
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Table 2. Bivariate analysis of STEMI patients that was done fibrinolytic using 
streptokinase regiment
Variables
Fibrinolytic
p valueFailed
n = 53
Successful
n = 52
Male sex, n (%) 47 (49.5%) 48 (50.5%) 0.527
Elderly ( > 75 years old), n (%) 4 (66.7%) 2 (33.3%) 0.410
Hypertension, n (%) 30 (62.5%) 18 (37.5%) 0.024*
Diabetes, n (%) 11 (64.7%) 6 (33.3%) 0.200*
Not smoker, n (%) 14 (60.9%) 9 (9.1%) 0.260
Killip class > 1, n (%) 15 (75%) 5 (25%) 0.015*
Onset ≥ 6 hours, n (%) 24 (82.8%) 5 (17.2%) 0.000*
Leukocytosis / neutrophilia, n (%) 45 (51.1%) 43 (48.9%) 0.760
Hyperglycemia, n (%) 20 (76.9%) 6 (23.1%) 0.002*
Increased creatinine level, n (%) 23 (54.8%) 19 (45.2%) 0.470
Anterior infarction, n (%) 39 (65%) 21 (35%) 0.001*
*statistically powerful to be included in multivariate analysis
Table 3. Multivariate analysis of failed fibrinolytic predictors
 Predictors p value OR  95% Confidence Interval
ypertension 0.074 2.43 0.92 - 6.44
Diabetes 0.26 2.00 0.89 - 2.05
Killip > 1 0.53 1.55 0.40 - 6.02
Onset ≥ 6 jam 0.000* 11.3 3.30 - 38.9
Hyperglycemia 0.005* 6.11 1.86 - 20.0
Anterior infarction 0.002* 10.5 1.93 - 14.4
suitability value. From the interobserver Kappa 
test performed we obtained a value of 0.85, which 
means that there was a very strong conformity 
between ECG observer. This study showed that 
there was 53 (50.5%) subjects who have failed 
fibrinolytic. The number of subjects who had 
an anterior infarction was 60 (57.1%). Table 1 
showed the characteristics of subjects. 
The subjects was divided into two groups, 
i.e. those who had failed fibrinolytic and those 
who had successful fibrinolytic. The bivariate 
analysis was conducted to find factors that 
can affect the result of fibrinolytic. In bivariate 
analysis, factors that have statistically significant 
differences in both groups were hypertension, 
diabetes, Killip class, onset, hyperglycemia, and 
anterior infarct location (shown in table 2). 
To examine the relationship between 
various independent variables on fibrinolytic 
failure, multivariate analysis was done by 
using logistic regression, with the inclusion 
criteria those who had p value <0.25. Based 
on multivariate analysis, the onset ≥ 6 hours, 
hyperglycemia, and the anterior infarction were 
associated independently with failed fibrinolytic 
(OR = 11.3, p = 0.000; OR = 6.11, p = 0.003 
and OR = 10.5, p = 0.001, respectively). Table 
3 shows the multivariable analysis. 
To determine the scoring system, first we 
performed the analysis and calculation of the 
weight value (score) from each independent 
predictors associated with fibrinolytic failure. 
From the calculation we found score is 1 for each 
predictors (table 4).
By looking at the score that has been 
obtained, scoring system based on probability 
may now be established. Ths scoring system 
model is based on the score of probability. From 
the calculation results, when the subject has 
an onset ≥ 6 hours, hyperglycemia, or infarct 
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Figure 1. Scoring card based on probability of subjects to get a failed fibrinolytic
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FIBRINOLYTIC PATIENTS SCORING CARD 
 BASED ON PROBABILITY  
 
Patient name :  
Complete data below. Use (V) mark in the box corresponding to the patient’s 
condition. 
 
      Predictor    Yes No  Patient score 
 
� STEMI onset  ≥ 6 hours    1     0   
� Hyperglycemia on arrival    1     0 
� Anterior infarction     1     0 
 
Total score 
 
Note: 
 Total score  Failed fibrinolytic probability (%) 
 
   0    12 %      
   1    48 % 
   2    97 % 
   3     99 % 
    
Figure 1. S o ing car  based on probability of subjects to get a failed 
fibrinolytic 
 
 
 
FIBRINOLYTIC PATIENTS SCORING CARD 
BASED ON CUTOFF POINT 
 
Patient name :  
Complete data below. Use (V) mark in the box corresponding to the patient’s 
condition. 
 
      Predictor    Ya Tidak  Skor pasien 
 
� STEMI onset ≥ 6 hours    1     0   
� Hyperglycemia on arrival    1     0 
� Anterior infarction     1     0 
 
Total score 
 
Note: 
Fibrinolytic therapy will fail if the patient had a total score of ≥ 2 
Fibrinolytic therapy will succeed if the patient had a total score of ≤ 1 
  
Table 4. Calculation of the weight value (score) from each independent 
predictors associated with fibrinolytic failure
Predictors B SE B/SE [B/SE]/x Score
Onset ≥ 6 jam 2.5 0.64 3.91 1.4 1
Hyperglycemia 1.74 0.61 2.85 1.0 1
Anterior infarction 1.58 0.52 3.03 1.1 1
location, each have score of 1. The probability 
is then calculated for each subject have failed 
fibrinolytic uses regression equation (table 5). 
Moreover, we can set up a scoring system 
based on the value of the cutoff point. This 
scoring system odel is derived from the value 
of sensitivity and specificity chart based on 
probability. Figure 1 and 2 were the scoring 
system chart based on probability as well as 
cut-off point. 
Discussion 
In this retrospective study, we investigated 
the predictors associated with fibrinolytic failure 
in 105 patients. Although fibrinolytic is one of 
the option for reperfusion in STEMI, but more 
than a third of patients do not respond well to 
this therapy and follow-up actions should be 
done in the form of rescue PCI.5 Determination 
of fibrinolytic results in this study is using ST 
segment resolution. Some lit ratur  suggests 
that ST segment resolution is better to determine 
prognosis, and may be more a marker of 
reperfusion failure when compared with TIMI 
flow. TIMI flow only see the blood flow in the 
epicardial coronary, while the ST segment is 
also reflects microvascular blood flow.6 For this 
reason, we use the ST segment resolution < 50% 
as fibrinolytic failure criteria.
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In this study, the use of fibrinolytic 
streptokinase is failed in 53 patients (50.5%). 
This is consistent with the existing literature 
and guidelines, that said streptokinase had a 
failure rate in nearly half of STEMI patients.5 This 
study found factors that do not affect fibrinolytic 
failures are gender, age, smoking history, value 
of leukocyte / neutrophil, and creatinine. In 
addition to the above factors, factors that predict 
failure of fibrinolytic but not independently are 
hypertension, diabetes and Killip class > 1, while 
independent predictor factors are the onset of 
STEMI ≥ 6 hours, hyperglycemia, and locations 
involving anterior infarction.
Gender was not a confounding factor in 
this study. In bivariate analysis, gender did not 
affect the results of fibrinolytic (p = 0.53). This 
is consistent with four previous studies, which 
reflected that although the literature said that men 
are more prone to the “no-reflow” phenomenon, 
but in clinical practice is rare to have fibrinolytic 
failure. Male make up the majority of the study 
subjects (90.5%). This is consistent with previous 
studies in which female experience less STEMI 
that was done fibrinolytic. Research by Sinkovic 
et al.7 showed that male consist of 78 of the 106 
subjects (73%). Other studies had similar results 
where men make up 60%, 82%, and 70% of 
subjects, respectively.8,9,10
This study shows that advanced age is not 
related to the failed fibrinolytic (p = 0.41). This is 
consistent with prior research.7,10. The different 
Figure 2. Scoring card based on cut-off value of subjects to get a failed fibrinolytic
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� STEMI onset ≥ 6 hours    1     0   
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Fibrinolytic therapy will fail if the patient had a total score of ≥ 2 
Fibrinolytic therapy will succeed if the patient had a total score of ≤ 1 
  
Table 5. Calculation of the probability (p) of each score based on a logistic 
regression
Patient’s 
score (S)
Constant 
(A)
Coefficient 
(B) y0 = BxS y = A+B
0 -2 1.908 0 -2 0.12
1 -2 1.908 1.908 -0.092 0.48
2 -2 1.908 5.816 3.816 0.97
3 -2 1.908 7.724 5.724 0.99
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results expressed by other study, where the older 
age correlated positively with fibrinolytic failure, 
but not independently,9 so it can be concluded 
that in general the elderly only have indirect effect 
on fibrinolytic results. This result have clinical 
implications, namely in elderly STEMI patients 
who will be given fibrinolytic, we can consider 
other factors than failed reperfusion, for example, 
the risk of bleeding or stroke risk.
Only a small proportion (21.9%) patients 
have no history of smoking in this study. Smoking 
history are not predictor of failed fibrinolytic 
in this study (p = 0.26). Kocas et al.10 found 
similar result, with the percentage of subjects 
who had a smoking history is 34.4% in the 
group of successful fibrinolytic and 55.4% in 
the group failed fibrinolytic (p = 0.08). This is 
contradicting with Rosencher et al.9, that found 
history of smoking was an independent predictor 
of successful fibrinolytic (OR = 1.75, p = 0.003). 
This difference is due to the basic characteristics 
of the subject in our research, where most 
subject have a history of smoking, which shows 
that smoking is still a problem that can not be 
separated from the life of the populations. This 
problem is a challenge for medical practitioners 
and stakeholders to improve health promotion 
efforts in reducing the prevalence of this 
traditional cardiovascular risk factors.
Leukocyte / neutrophil and creatinine 
values was not predictor of failed fibrinolytic in this 
study (p = 0.76; p = 0.47). Increased creatinine 
level in arrival has proven to be an independent 
predictor of 30-day mortality in patients with 
STEMI. 11 Therefore, when predicting the failure 
of fibrinolytic, should not wait for these laboratory 
parameters. We expect this result to accelerate 
time to treatment in patients who was given 
fibrinolytic.
Hypertension affects the failed fibrinolytic, 
but not independently in this study. Bivariate 
analysis get results of p = 0.024, while univariate 
get results of p = 0.074. The different results 
obtained by several studies who found that 
hypertension has no effect on the outcome of 
fibrinolytic.7,9,10
A Killip class > 1 have effect on fibrinolytic 
failure, but not independently in this study. 
Bivariate analysis got results of p = 0.015, while 
univariate get results of p = 0.53. The different 
results obtained by Rosencher et al.9 and Kocas 
et al.10 who found that Killip class has no effect on 
the outcome of fibrinolytic. This result suggests 
that the presence of heart failure that occurs 
arrival might only indirectly affect the results of 
fibrinolytic, which is because in this study, heart 
failure is almost entirely in patients with infarction 
in the anterior leads.
History of diabetes have effect on fibrinolytic 
failure, but not independently. Bivariate analysis get 
results of p = 0.2, were univariate get results of p 
= 0.26. This is consistent with previous research.10 
The different results showd other study who found 
that diabetes is a predictor of failure of fibrinolytic.8 
The results of this study may be because the 
majority (14 of 17) of patients with diabetes have 
hyperglycemia on admission, but less than half of 
patients who experience hyperglycemia is diabetic 
(12 of 26 patients).
Onset STEMI ≥ 6 hours was an independent 
predictor of fibrinolytic failure in this study. This 
is consistent with several previous studies. 
Research by Rosencher et al.9 showed that onset 
fibrinolysis ≤ 1 hour is an independent predictor 
of the success of fibrinolytic (OR = 1.76, p = 
0.006). Kocas et al.10 also mention that there 
are significant differences between the onset of 
STEMI with fibrinolytic failure, where the subject 
who experienced failure had a mean onset time 
of 180 minutes compared to having successful 
fibrinolysis who had 150 minutes. Sinkovic et al.7 
have different result in which STEMI onset is not 
related to the results of fibrinolytic. In another 
study, in patients with STEMI performed primary 
PCI, the onset ≥ 6 hours has been identified as an 
independent predictor of failure of reperfusion.12 
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These results provide clinical implications which 
is STEMI patients who arrive late at the hospital 
should be given extra attention when determining 
the reperfusion strategy.
Hyperglycemia was an independent predictor 
of fibrinolytic failure in this study (p = 0.005). This 
result fit in research conducted by Kocas et al.10 
where arrival hyperglycemia is an independent 
predictor of fibrinolytic failure. Increase in blood 
sugar is frequent in patients treated with STEMI, 
with a prevalence of 14-50%.10,13. In this study, the 
prevalence of hyperglycemia amounted to 24.8%. 
Although several studies have been looking for 
the effects of hyperglycemia on the cardiovascular 
system, there has been no consensus on the 
definition of acute hyperglycemia in patients with 
STEMI. Some studies such as Wahab et al.13 and 
Kocas et al.10 was using criteria based on guidelines 
from the American Diabetes Association, which is> 
198 mg/dL, but in our study we use criteria based 
on the guidelines of PERKENI i.e.  ≥ 200 mg/dL.14 
The results in this study also indicates that while 
diabetes is one of the traditional cardiovascular 
risk factors and the phenomenon of “no-reflow”, 
but in patients with STEMI and given fibrinolytic, it 
is preferred to use random blood sugar tests.
Infarct ion involv ing anter ior  is  an 
independent predictor of fibrinolytic failure in 
this study. This is consistent with other research 
where anterior infarcts is a predictor of failure 
fibrinolytic.9 However, other study have different 
result that state although STEMI patients who 
failed fibrinolytic have more that involving 
anterior infarction, infarct location not associated 
statistically with fibrinolytic failure.10
These three independent predictors of failed 
fibrinolysis, namely onset ≥ 6 hours, hyperglycemia, 
and anterior infarct location can easily be checked 
in STEMI patients that will be given fibrinolytic. Only 
by anamnesis, a simple laboratory examination, 
and ECG, clinicians can estimate the results of 
fibrinolytic. To further simplify and accelerate the 
predictions, clinicians may use a scoring system 
that has been created. In this study, the scoring 
system have sensitivity of 53% and a specificity 
of 94% in predicting the failure of fibrinolytic. 
The results support the research hypothesis that 
the scoring system is capable to predict failed 
fibrinolytic in STEMI patients.
Study Limitations
This study was done retrospectively, so it 
has a lower level of evidence than a prospective 
study. Some of the variables examined in this 
study was derived from previous studies. Other 
variables not examined in this study were the 
body mass index and door to needle time, due to 
the limitations in the data in medical record.
Conclusion 
 A scoring system consisting of onset ≥ 
6 hours, hyperglycemia in arrival, and anterior 
infarct location, can be used to predict failed 
fibrinolytic in STEMI patients using streptokinase 
regiment, with 53% sensitivity and 94% specificity. 
Failed fibrinolytic was predicted in patient who 
had score of at least 2, with a probability of 
97%.
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